Evidence map›Paper›PMID 27013801›Full record

ArticlePharmacognosy magazine2015

Anticancer Activity of Chloroform Extract and Sub-fractions of Nepeta deflersiana on Human Breast and Lung Cancer Cells: An In vitro Cytotoxicity Assessment.

Mai M Al-Oqail, Ebtesam S Al-Sheddi, Maqsood A Siddiqui, Javed Musarrat, Abdulaziz A Al-Khedhairy, Nida N Farshori

Open access · bronzeAbstract read
In one paragraph

Article in Pharmacognosy magazine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Bioactive Potential and Health Benefits ofFood science & nutrition · 2025
    Review
  3. Article
  4. Article
  5. Cytotoxic Effects of SomePlants (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Biological Evaluation of Different Extracts of Aerial Parts ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  9. Article
  10. Pharmacognosy magazine · 2018
    Article
  11. TheBiochemistry and biophysics reports · 2017
    Article
  12. SiOCancer gene therapy · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mai M Al-OqailDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Kingdom of Saudi Arabia.
Ebtesam S Al-SheddiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Kingdom of Saudi Arabia.
Maqsood A SiddiquiDepartment of Zoology, Al-Jeraisy Chair for DNA Research, College of Science, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Javed MusarratDepartment of Zoology, Al-Jeraisy Chair for DNA Research, College of Science, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Abdulaziz A Al-KhedhairyDepartment of Zoology, Al-Jeraisy Chair for DNA Research, College of Science, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Nida N FarshoriDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Kingdom of Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer is one of the major causes of death worldwide. The plant-derived natural products have received considerable attention in recent years due to their diverse pharmacological properties including anticancer effects. Nepeta deflersiana (ND) is used in the folk medicine as antiseptic, carminative, antimicrobial, antioxidant, and for treating rheumatic disorders. However, the anticancer activity of ND chloroform extract has not been explored so far.

objectivesThe present study was aimed to investigate the anticancer activities of chloroform Nepeta deflersiana extract and various sub-fractions (ND-1-ND-15) of ND against human breast cancer cells (MCF-7) and human lung cancer cells (A-549). MATERIALS AND

methodsThe 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide and neutral red uptake assays, and cellular morphological alterations using phase contrast light microscope were studied. Cells were exposed with 10-1000 μg/ml of sub-fractions of ND for 24 h.

resultsResults showed that selected sub-fractions of the chloroform extract significantly reduced the cell viability of MCF-7 and A-549 cells, and altered the cellular morphology in a concentration-dependent manner. Among the sub-fractions, ND-10 fraction showed relatively higher cytotoxicity compared to other fractions whereas, ND-1 did not cause any cytotoxicity even at higher concentrations. The A-549 cells were found to be more sensitive to growth inhibition by all the extracts as compared to the MCF-7 cells.

conclusionThe present study provides preliminary screening of anticancer activities of chloroform extract and sub-fractions of ND, which can be further used for the development of a potential therapeutic anticancer agent. SUMMARY: Nepeta deflersiana extract exhibit cytotoxicity and altered the cellular morphology. Sub-fractions of the chloroform extract of Nepeta deflersiana reduced the cell viability of MCF-7 and A-549 cells. Among the sub-fractions, ND-10 fraction showed relatively higher cytotoxicity. The A-549 cells were found to be more sensitive as compared to the MCF-7 cells. Abbreviations used: MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; NRU: Neutral red uptake; DMEM: Dulbecco's modified eagle medium; FBS: Fetal bovine serum; PBS: Phosphate buffer saline; DMSO: Dimethyl sulfoxide.

Indexed as

A-549 cellsanticancercytotoxicityMCF-7 cellsNepeta deflersiana

Identifiers

PMID27013801
PMCPMC4787095
OpenAlexW2281970984

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.